All News Bionime Corporation

Equities

4737

TW0004737002

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-05 pm EDT			5-day change	1st Jan Change
69.5 ^TWD	+2.21%		+1.02%	-7.09%

Mar. 15	Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
Bionime Corporation Announces Dividend for the Year Ended December 31, 2023	Mar. 14	CI
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License	23-10-13	CI
Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer	23-08-18	CI
Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee	23-08-09	CI
Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee	23-06-30	CI
Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023	23-06-30	CI
Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director	23-06-30	CI
Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Bionime Corporation Revises Cash Dividend for 2022	23-05-10	CI
Bionime Corporation Appoints Chen Hui-Zhen as Corporate Governance Officer	23-05-10	CI
Bionime Corporation Announces Cash Dividend for 2022	23-03-14	CI
Bionime Corporation Announces Resignation of Tai,Tsung-Kai as Institutional Director, Effective April 30, 2023	23-03-03	CI
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Bionime Corporation Approves the Factory Area to Expand Building the Clean Room to Accommodate Production Equipment and Increase Production Capacity	22-11-09	CI
Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon	22-11-02	AQ
Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring	22-11-01	AQ
Bionime RIGHTEST iFree CGM System - An Innovative Approach to Keep Track of Every One Health	22-10-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Bionime Corporation

Equities

4737

TW0004737002

All News

Filters